Seidal T, Angervall L, Kindblom L G
Department of Pathology, University of Gothenburg, Sahlgren Hospital, Sweden.
APMIS. 1990 Dec;98(12):1105-12. doi: 10.1111/j.1699-0463.1990.tb05041.x.
Eighteen light microscopically undifferentiated small and dark cell malignancies, previously studied ultrastructurally and immunohistochemically in terms of desmin, vimentin and myoglobin expression, were analyzed using mono- and polyclonal antibodies to muscle-specific isoforms of myosin and actin. For comparison, 10 characteristic rhabdomyosarcomas, 5 alveolar and 5 embryonal, were included in the study. A polyclonal antibody to skeletal myosin produced an indistinct staining in all the alveolar and embryonal rhabdomyosarcomas. The staining was most prominent in well-differentiated rhabdomyoblastic tumor cells. In the analysis of the small and dark cell malignancies, this antibody produced a weak and indistinct positivity which can not be interpreted with certainty as an expression of muscle-specific properties. An antibody directed at the alpha and gamma isoforms of actin, which are present in smooth and striated muscle, produced a distinct positive staining in all the alveolar and embryonal rhabdomyosarcomas and in 8/18 small and dark cell malignancies, 7 of which were also shown to express desmin. An antibody directed at the alfa-smooth muscle isoform of actin did not produce any positive staining in any of the tumors. The present study indicates that both muscle-specific actin and desmin can be expressed in tumors lacking ultrastructural evidence of a rhabdomyoblastic differentiation and that the combined use of monoclonal antibodies to desmin and muscle-specific actin is of value when it comes to recognizing rhabdomyosarcomas within the group of undifferentiated small and dark cell malignancies of soft tissue tumors.